iCARE Hepatitis C Virus Rapid Test

If you’re looking for a quick, lab-accurate HCV test, the iCARE Hepatitis C Vira n Rapid Test is a great option. The rapid test enables healthcare providers to quickly and easily provide at-risk patients with lab results. The iCARE Hepatitis C Virus Rapid Test is a WHO PQ LISTED HEPATITIS C RAPID TEST, ensuring high standards of accuracy and reliability for HCV detection.

iCARE HCV Rapid Test Enables Healthcare Providers to Deliver Fast, Lab Accurate Test Result

Healthcare providers can quickly and accurately detect the presence of HCV antibodies using a simple POC test. The test results can be delivered in less than 20 minutes, which allows healthcare providers to identify individuals at risk for HCV and offer counseling or treatment when necessary. In an outbreak situation, timely identification of infected patients can help reduce anxiety among those who may be exposed to the virus. As a WHO PQ LISTED HCV RAPID TEST, the iCARE HCV Rapid Test meets global standards for quality and performance, making it a trusted solution for healthcare professionals.

The iCARE HCV Rapid Test is a point-of-care test for the detection of antibodies to HCV. It is available in a variety of settings, including correctional facilities, public health clinics, and needle exchange programs. It is also being used at NSPs and urban STI clinics. Being a WHO PQ LISTED HCV RAPID TEST, it is widely recognised for its efficiency and accuracy in different healthcare environments.

The iCARE HCV Rapid Test is a simple, quick and cost-effective way to provide fast lab results for patients. The rapid, accurate results are critical in the management of patients with HCV. Providing a rapid and accurate result can save time, money and anxiety for patients. This WHO PQ LISTED HEP C RAPID TEST ensures that healthcare providers can confidently rely on its precision and efficiency for rapid HCV detection.

The iCARE HCV Rapid Test is a highly accurate and quick HCV antigen test. It is compatible with a range of clinical laboratory equipment. It is fast and inexpensive and enables healthcare providers to deliver a lab-accurate test result within 20 to 30 minutes. With its certification as a WHO PQ LISTED HEP C RAPID TEST, this diagnostic tool guarantees reliability in various clinical and public health settings.

By being a WHO PQ LISTED HEPATITIS C RAPID TEST, the iCARE HCV Rapid Test adheres to the highest international standards, providing reliable results for early HCV detection and treatment planning.

About Author:

JAL Medical Singapore
Mr. Andre Han

Managing Director, JAL Medical Singapore

Mr. Andre Han is the Managing Director of JAL Medical Singapore, a strategic subsidiary of a publicly listed biomedical manufacturer headquartered in Hsinchu, Taiwan. The parent company is internationally recognized for its ISO 13485 and GMP-certified production capabilities, delivering high-quality diagnostic solutions to global healthcare markets.
With over 20 years of experience in the medical device industry, Mr. Han brings deep expertise in commercial strategy, product development, and international market expansion. He oversees a comprehensive portfolio that includes in-vitro diagnostic test kits and proprietary blood glucose monitoring systems tailored for both clinical and home environments. Under Mr. Han’s leadership, JAL Medical has:

  • Distributed hundreds of millions of rapid diagnostic test kits globally
  • Secured long-term national tenders in South Africa
  • Expanded into key markets including Laos, Mongolia, Ghana, Kenya, Ukraine, Nigeria, and Japan
Beyond commercial operations, Mr. Han spearheads consultancy initiatives focused on:
  • Rapid test innovation and development
  • Facility optimization and regulatory alignment
  • Enhancing quality, reliability, and affordability across product lines
His strategic vision and commitment to innovation continue to position JAL Medical Singapore as a trusted provider of accessible, high-performance healthcare technologies worldwide.

Listening Article